Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model

Phytotherapy Research

Volumn 25, Issue 1, 2011, Pages 33-37

  Wang, Li Hong ^a   Yu, Chang Hua ^a   Fu, Ying ^a   Li, Qiang ^a   Sun, Yu Qian ^a  

^a Medical University   (China)

Author keywords

berberine; diabetes; inward rectifier potassium current; ischemic arrhythmia

Indexed keywords

BERBERINE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; MALE; MEMBRANE STEADY POTENTIAL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POTASSIUM CURRENT; PROTEIN EXPRESSION; RAT; SCORING SYSTEM;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BERBERINE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; MALE; MEMBRANE POTENTIALS; MYOCARDIAL INFARCTION; PATCH-CLAMP TECHNIQUES; POTASSIUM; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 78650669826     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3097     Document Type: Article

References (18)

1. Ai J, Wang N, Yang M, Du ZM, Zhang YC, Yang BF., 2005. Development of Wistar rat model of insulin resistance. World J Gastroenterol 11: 3675-3679.
2. Caro JJ, Ward AJ, O'Brien JA., 2002. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 25: 476-481.
3. Chang PN, Mao JC, Huang SH, Ning L, Wang ZJ, On T, Duan W, Zhu YZ., 2006. Analysis of cardioprotective effects using purified Salvia miltiorrhiza extract on isolated rat hearts. J Pharmacol Sci 101: 245-249.
4. Diaz RJ, Zobel C, Cho HC, Batthish M, Hinek A, Backx PH, Wilson GJ., 2004. Selective inhibition of inward rectifier K+ channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes. Circ Res 95: 325-332.
5. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD., 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10: 1344-1351
6. Ni YX,. 1988. Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research [in Chinese ]. Zhong Xi Yi Jie He Za Zhi 8: 711-713
7. Sun J, Huang SH, Tan BK, Whiteman M, Zhu YC, Wu YJ, Ng Y, Duan W, Zhu YZ,. 2005. Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction. Life Sci 76: 2849-2860.
8. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B., 1988. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22: 447-455.
9. Wild S, Roglic G, Green A, Sicree R, King H., 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
10. Xie W, Xing D, Zhao Y, Su H, Meng Z, Chen Y, Du L., 2005. A new tactic to treat postprandial hyperlipidemia in diabetic rats with gastroparesis by improving gastrointestinal transit. Eur J Pharmacol 510: 113-120.
11. Xing Y, Yue P, Sun LH, Zhao WX, Wang Y, Zhang Y, Liu X, Lu YJ, Yang BF., 2007. Effect of Daming capsule on expression of connexin43 isoforms in hyperlipemic rat's cardiac muscle. Zhongguo Zhong Yao Za Zhi 32: 1440-1445.
12. Yamakoshi Y, Fukasawa H, Yamauchi T, Waki H, Kadowaki T, Shudo K, Kagechi H., 2002. Determination of endogenous levels of retinoic acid isomers in type II diabetes mellitus patients. Possible correlation with HbA1c values. Biol Pharm Bull 25: 1268-1271.
13. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z., 2007. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491.
14. Yang B, Lu Y, Wang Z., 2008. Control of cardiac excitability by microRNAs. Cardiovasc Res 79: 571-580.
15. Zhang F, Ye C, Li G, Ding W, Zhou W, Zhu H, Chen G, Luo T, Guang M, Liu Y, Zhang D, Zheng S, Yang J, Gu Y, Xie X, Luo M., 2003. The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp Anim 52: 401-407.
16. Zhao XY, Qiao GF, Li BX, Chai LM, Li Z, Lu YJ, Yang BF., 2009. Hypoglycaemic and hypolipidaemic effects of emodin and its effect on L-Type calcium channels in dyslipidaemic-diabetic rats. Clin Exp Pharmacol Physiol 36 (1): 29-34
17. Zhou L, Zuo Z, Chow MS., 2005. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345-1359.
18. Zimmet P, Alberti KG, Shaw J., 2001. Global and societal implications of the diabetes epidemic. Nature 414: 782-787.